Current and New Concepts in the Biology and Treatment of Head and Neck Cancer
Saturday, April 3, 2010
7:15 am – 1:00 pm
Four Seasons Hotel
Boston, MA
Quicklinks
Course Objectives | Agenda | Faculty
Registration Information
Course Objectives
This course will provide an update on the current standard of care and new approaches for treating head and neck cancer. It is designed for medical and radiation oncologists; surgeons; otolaryngologists; dentists and other interested clinicians. Participants will gain insight on developing appropriate treatment plans for patients, experimental therapeutic approaches in development, and new discoveries in the biology of the disease. In addition to hearing about medical, surgical, and radiation advances, attendees will also learn practical tips for pain and symptom management.
About the Head and Neck Oncology Program at Dana-Farber/ Brigham and Women's Cancer Center
The Head and Neck Oncology Program at Dana-Farber/Brigham and Women's Cancer Center is the region's most comprehensive multidisciplinary service dedicated exclusively to patients with head and neck cancers. Specialists evaluate and treat all types and stages of head and neck cancers, from early lesions to the rarest and most challenging cases. Through this program, referring physicians and their patients have access to highly experienced clinicians from numerous specialties, including head and neck surgery, medical and radiation oncology, dentistry, oral surgery, reconstructive surgery, nutrition services, social work, speech, voice, and swallowing therapy. The program is active in both basic research which helps improve the understanding of the biology of the disease as well as clinical research aimed at developing innovative new treatments for patients.
Agenda
7:15 am
Registration and Continental Breakfast
7:45 am
Welcome and Introduction
Robert I. Haddad, MD
8:00 am
The Integration of Chemotherapy in Curative Treatment of Head and Neck Cancer
Marshall R. Posner, MD
8:30 am
Should We Alter Therapy for HPV-related Oropharynx Cancer?
Roy B. Tishler, MD, PhD
9:00 am
Reirradiation for Recurrent Head and Neck Cancers
David Sher, MD, MPH
9:30 am
Neck Management in Head and Neck Cancer: Historical Perspectives and Current
Practice
Laura Ann Goguen, MD, FACS
10:00 am
Pain and Palliative Care in the Head and Neck Cancer Patient
Tracy A. Balboni, MD, MPH
10:30 am
Break
10:45 am
Surgical Management of Tumors of the Orbit
Donald J. Annino, Jr., MD, DMD
11:15 am
Evolving Role of the EGFR Inhibitors in Head and Neck Cancer
Jochen H. Lorch, MD, MS
11:45 am
Oral Health Considerations in Head and Neck Cancer Survivorse
Nathaniel S. Treister, DMD, DMSc
12:15 pm
Panel Discussion: Challenging Cases in Head and Neck Cancer
Panelists: Laura Ann Goguen, MD, FACS
Marshall Posner, MD
Roy B. Tishler, MD, PhD
1:00 pm
Lunch
Faculty
Robert I. Haddad, MD, Course Director
Clinical Director, Head and Neck Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine
Harvard Medical School
Donald J. Annino, Jr., MD, DMD
Surgical Oncologist
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Surgery
Harvard Medical School
Tracy A. Balboni, MD, MPH
Radiation Oncologist
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Radiation Oncology
Harvard Medical School
Laura Ann Goguen, MD, FACS
Surgical Oncologist
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Surgery
Harvard Medical School
Jochen H. Lorch, MD, MS
Medical Oncologist
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Medicine
Harvard Medical School
Marshall R. Posner, MD
Director, Head and Neck Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine
Harvard Medical School
David Sher, MD, MPH
Radiation Oncologist
Dana-Farber/Brigham and Women's Cancer Center
Instructor in Radiation Oncology
Harvard Medical School
Roy B. Tishler, MD, PhD
Disease Center Leader, Head and Neck Radiation Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Radiation Oncology
Harvard Medical School
Nathaniel Treister, DMD, DMSc
Associate Surgeon
Brigham and Women's Hospital;
Assistant Professor of Oral Medicine
Harvard School of Dental Medicine
Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.
Harvard Medical School designates this educational activity for a maximum of 4.75 AMA PRA Category 1 credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
Registration Information
Registration Fee: $35 and includes course materials, continental breakfast and lunch. The registration fee is non-refundable.
If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email kwooten@partners.org or call (800) 553-3787.
